Lymphoma, Extranodal NK-T-Cell
Item
newly diagnosed enktl
boolean
C1955906 (UMLS CUI [1])
Age
Item
age:18-69years
boolean
C0001779 (UMLS CUI [1])
Ann Arbor lymphoma staging system | Cervical lymph node Involvement with
Item
ann arbor stage ie,or stage iie with cervical lymph node involvement
boolean
C0432516 (UMLS CUI [1])
C1279046 (UMLS CUI [2,1])
C1314939 (UMLS CUI [2,2])
Measurable lesion
Item
at lease one measurable lesion
boolean
C1513041 (UMLS CUI [1])
Chemotherapy Regimen Firstly | Therapeutic radiology procedure Firstly
Item
receive no chemotherapy or radiotherapy before
boolean
C0392920 (UMLS CUI [1,1])
C1279901 (UMLS CUI [1,2])
C1522449 (UMLS CUI [2,1])
C1279901 (UMLS CUI [2,2])
ECOG performance status
Item
eastern cooperativeoncology group performance status of 0 to 2.
boolean
C1520224 (UMLS CUI [1])
Hematologic function | White Blood Cell Count procedure | Neutrophil count
Item
adequate hematologic function (eg, white blood cell ≥ 3×10e9/l,neutrophils count
boolean
C0221130 (UMLS CUI [1])
C0023508 (UMLS CUI [2])
C0200633 (UMLS CUI [3])
Platelet Count measurement | Renal function | Creatinine measurement, serum | Creatinine clearance measurement | Liver function | Bilirubin, total measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement
Item
≥1.5×10e9/l, and platelet count≥ 100×10e9/l),renal function (eg, serum creatinine≤1.5 mg/dl and creatinine clearance ≥50 ml minute), and hepatic function (e.g, total bilirubin≤ 2 times the upper limit of normal and aspartate and alanine transaminase levels ≤ 3 times the upper limit of normal)
boolean
C0032181 (UMLS CUI [1])
C0232804 (UMLS CUI [2])
C0201976 (UMLS CUI [3])
C0373595 (UMLS CUI [4])
C0232741 (UMLS CUI [5])
C0201913 (UMLS CUI [6])
C0201899 (UMLS CUI [7])
C0201836 (UMLS CUI [8])
Mismatch Inclusion criteria
Item
mismatch the inclusion criteria
boolean
C1881865 (UMLS CUI [1,1])
C1512693 (UMLS CUI [1,2])
Central Nervous System Involvement systematic | Malignant Neoplasms | Comorbidity Compliance behavior Limited
Item
systematic central nervous system involvement, previous or concomitant malignancies and any coexisting medical problems that could cause poor compliance with the study protocol.
boolean
C3714787 (UMLS CUI [1,1])
C1314939 (UMLS CUI [1,2])
C0220922 (UMLS CUI [1,3])
C0006826 (UMLS CUI [2])
C0009488 (UMLS CUI [3,1])
C1321605 (UMLS CUI [3,2])
C0439801 (UMLS CUI [3,3])
Primary Lesion | Upper respiratory tract
Item
primary lesion not from the upper respiratory
boolean
C1402294 (UMLS CUI [1])
C0458578 (UMLS CUI [2])